Skip to content

MDMA: all studies

Page 6 of 345: studies 51 to 60 of 3,446, newest first. Back to the MDMA overview

Research

Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.

Neuropsychopharmacology July 1, 2026 Denis Arikci, Joran Borgulya, Isabelle Straumann et al. 1 citation

Based on its in vitro profile and preliminary evidence, 4-bromo-2,5-dimethoxyphenethylamine (2C-B) may have psychoactive properties that are similar to 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin, which are investigated for the treatment of posttraumatic stress disorder and depressive disorders. We compared acute effects of 2C-B (10, 20, and 30 mg), 125 mg MDMA, and 25 mg psilocybin...

Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.

Psychopharmacology July 1, 2026 Sarah Ann Smith, Haseeb Mohammad, Lik Hang N Lee et al.

Interest in psychedelic drugs has increased rapidly because of their potential therapeutic role in psychiatric disorders. Impairments in the sociocognitive skills needed to build and maintain social relationships are prominent features of many psychiatric and neurodevelopmental disorders. Emerging evidence suggests that compounds such as 3,4-methylenedioxymethamphetamine (MDMA), lysergic acid...

DOI: 10.1007/s00213-026-07110-y (opens in new tab) Full text (opens in new tab) Psychedelic drugs Scoping review Social cognition

MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder

BMJ Open July 1, 2026 Kirsten Morley, Shalini Arunogiri, Katherine L. Mills et al.

INTRODUCTION: The treatment of comorbid post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD) is significantly more challenging than the treatment of either disorder alone. While gold standard evidence-based treatments exist for this comorbidity, clinically significant improvements are only observed in approximately half of clinical trial participants. The use of adjunctive...

Consumo recreativo de MDMA: un estudio sobre jóvenes en España

Escritos de Psicología / Psychological Writings June 29, 2026 Diego Fernández Piedra, A. López, Enrique Gallego-Granero et al.

Introduction: MDMA use among young people in Spain is shaped by psychosocial factors that guide consumption patterns, motivations, and risk-reduction strategies. Objective: To investigate consumption patterns, risk perception, and consumption management (strategies and practices aimed at regulating use) in recreational contexts among young people in Spain. Method: A mixed-methods design was...

DOI: 10.24310/escpsi.19.1.2026.21454 (opens in new tab) MDMA Consumption sociology Psychosocial Focus group +6

Protocol for a qualitative mechanistic study of MDMA with a sample of psychoanalytic psychotherapists: A phenomenological investigation

PLoS One June 18, 2026 Elisa Liberati, Hv Curran, Peter Fonagy et al.

INTRODUCTION: Methylenedioxymethamphetamine (MDMA)-assisted psychotherapy (MDMA-AP) is a potentially transformative intervention for post-traumatic stress disorder (PTSD). Despite encouraging Phase III trial results, the psychological mechanisms underpinning MDMA's therapeutic effects remain insufficiently understood. Existing research on MDMA has emphasised neurobiological processes but has...

DOI: 10.1371/journal.pone.0350728 (opens in new tab) MDMA Grounded theory Interpretative phenomenological analysis Thematic analysis +14

MDMA-induced CYP2D6 inhibition: concentration-dependent variability using dextromethorphan as a probe

Drug Metabolism and Personalized Therapy June 16, 2026 Faezeh Ahmadi, Hoda Lavasani, Mohammadhosein Keshvadi et al.

OBJECTIVES: Ecstasy is commonly abused due to entactogenic effects. Although our previous studies on isolated perfused rat model confirmed inhibition of CYP2D6 by MDMA, the time for enzyme recovery was different when mirtazapine and tramadol were used as substrates. Therefore, present study intended to investigate CYP2D6 inhibition by MDMA using dextromethorphan as a well-known probe. Two...

Semi-Quantitative Estimation of MDMA Tablet Dosage and Cocaine/Ketamine Purity Using a Simple to Operate Field-Portable Device

ChemRxiv June 9, 2026 Matthew Gardner, Alexander Power, Anca Frinculescu et al. preprint

High-dose MDMA tablets and variable-purity cocaine and ketamine samples are commonly encountered by drug checking services and police forces in the United Kingdom and Europe. At the time of writing, there are few simpleto-operate field-portable technologies that provide semi-quantitative information on MDMA tablet dosage or cocaine and ketamine purity at the point of sampling. We previously...

Understanding How Trait Negative Emotionality (NEM) Influences Social Connectedness and Responses to ± 3,4-Methylenedioxymethamphetamine (MDMA)

University of Chicago June 6, 2026 Ruiyan Hu

Negative Emotionality (NEM) is a trait measure that reflects a tendency toward experiencing intense negative emotions and heightened reactivity to perceived threats or stressors, contributing to challenges with social integration and interpersonal relationships. This secondary analysis in healthy volunteers (N = 30) employed a within-subject, double-blind, placebo-controlled design to...

DOI: 10.6082/2hxmy-m0z74 (opens in new tab) Trait Social connectedness Personality Population +9

The Role of the Basolateral and Central Amygdala During Heroin Withdrawal and 3,4-Methylenedioxymethamphetamine Administration

UNC Libraries June 5, 2026 Charlotte Rubin

Opioid use disorder (OUD) is characterized by dependence, withdrawal, and high relapse risk, yet the neuroimmune mechanisms underlying withdrawal in the amygdala remain poorly understood. This study investigated whether 3,4-methylenedioxymethamphetamine (MDMA) modulates heroin withdrawal–induced neuroinflammation in the central amygdala (CeA) and basolateral amygdala (BLA). Adult male...

DOI: 10.17615/32dy-yq54 (opens in new tab) MDMA Heroin Basolateral amygdala Cytokine +6

MDMA-Assisted Therapy for Social Anxiety Disorder: A Randomized, Open-label, Wait-list Controlled Trial

June 4, 2026 Jason B. Luoma, M. Kati Lear, Brian Pilecki et al. preprint

Background: ±3,4-methylenedioxymethamphetamine (MDMA) has positive effects on socio-emotional processing and MDMA-Assisted Therapy (MDMA-AT) showed promise for treating SAD in a previous placebo-controlled trial. Aims: Develop a preliminary estimate of clinical response and safety for MDMA-AT versus waitlist in adults with SAD. Secondary aims included refinement of a standardized psychotherapy...

DOI: 10.31234/osf.io/a9x6d_v1 (opens in new tab) Social anxiety Randomized controlled trial Adverse effect Clinical trial +3